Enzymatic methods to generate high yields of sequence specific RNA oligonucleotides with extreme precision

US12325873B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12325873-B2
Application numberUS-202318152367-A
CountryUS
Kind codeB2
Filing dateJan 10, 2023
Priority dateApr 24, 2019
Publication dateJun 10, 2025
Grant dateJun 10, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are synthetic methods for producing sequence-specific RNA oligonucleotides that eliminate impurities produced in prior art methods. In one aspect, an end-protected capture DNA complementary to a portion of the product RNA is employed. In another aspect, the template DNA is covalently or noncovalently linked to the RNA polymerase, either directly or through the use of a nontemplate DNA. In a third aspect, a flow chamber is employed. All of the methods can be used in combination.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of synthesizing a product RNA, the method comprising preparing a reaction mixture comprising a functional template DNA for the product RNA, and an RNA polymerase under conditions for RNA synthesis, wherein the RNA polymerase is noncovalently linked to a nontemplate DNA that is 10 nucleotides or longer in length, and wherein the nontemplate DNA is complementary to a minimum of 10 nucleotides of the template DNA upstream of the transcription start site, or wherein the nontemplate DNA is complementary to all or part of the entire template strand DNA in the coding region, wherein the nontemplate DNA and the RNA polymerase are immobilized to a solid support, and wherein the reaction mixture and the solid support are contained in a reaction chamber of a fluidic chip, the fluidic chip comprising fluidic paths for reagent delivery and product RNA removal, and synthesizing the product RNA in the reaction mixture and continuously removing the product RNA from the reaction chamber while flowing fresh RNA synthesis reagents into the reaction chamber, wherein the RNA polymerase comprises an avidin-binding peptide, the nontemplate DNA comprises a 3′ or 5′ biotin label respectively, and the RNA polymerase is noncovalently linked to the nontemplate DNA via a bead support that binds both the avidin-binding peptide and the biotin. 2. The method of claim 1 , wherein the reaction chamber is in operable communication with a downstream chamber comprising an immobilized reagent that specifically binds full-length product RNA, wherein the immobilized reagent does not bind less than full-length RNA and double-stranded RNA impurities. 3. The method of claim 1 , wherein the support is a microparticle or a bead. 4. The method of claim 1 , wherein RNA synthesis is conducted under low salt conditions of 0 to 50 mM. 5. The method of claim 1 , wherein RNA synthesis is conducted under high salt conditions of 50 to 1000 mM. 6. The method of claim 1 , wherein the reaction mixture further comprises a capture DNA that is 3′ end protected, and is complementary to 8 to 20 nucleotides at the 3′ end of the product RNA. 7. The method of claim 6 , wherein the 3′ end of the capture DNA comprises 3′ amino, 3′-deoxy (H), 3′-phosphorylation, 3′-O-methyl, 3′-fluorophore, 3′-biotin, 3′-azide, 3′-fluoro, 3′-PEG, or a 3′-mismatched base. 8. The method of claim 1 , further comprising purifying the product RNA. 9. The method of claim 8 , further comprising removing the capture DNA after product RNA synthesis. 10. A method of synthesizing a product RNA, the method comprising, preparing a reaction mixture comprising a functional template DNA for the product RNA, and an RNA polymerase under conditions for RNA synthesis, wherein the RNA polymerase is covalently linked to a nontemplate DNA that is 10 nucleotides or longer in length, and wherein the nontemplate DNA is complementary to a minimum of 10 nucleotides of the template DNA upstream of the transcription start site, or wherein the nontemplate DNA is complementary to all or part of the entire template strand DNA in the coding region, wherein the nontemplate DNA and the RNA polymerase are immobilized to a solid support, and wherein the reaction mixture and the solid support are contained in a reaction chamber of a fluidic chip, the fluidic chip comprising fluidic paths for reagent delivery and product RNA removal, and synthesizing the product RNA in the reaction mixture and continuously removing the product RNA from the reaction chamber while flowing fresh RNA synthesis reagents into the reaction chamber, wherein the RNA polymerase comprises a haloalkane dehalogenase tag, and wherein the nontemplate DNA is covalently linked to the haloalkane dehalogenase tag of the RNA polymerase via a 3 ′ or 5 ′halogen-modification. 11. The method of claim 10 , wherein the reaction chamber is in operable communication with a downstream chamber comprising an immobilized reagent that specifically binds full-length product RNA, wherein the immobilized reagent does not bind less than full-length RNA and double-stranded RNA impurities. 12. The method of claim 10 , wherein the support is a microparticle or a bead. 13. The method of claim 10 , wherein RNA synthesis is conducted under low salt conditions of 0 to 50 mM. 14. The method of claim 10 , wherein RNA synthesis is conducted under high salt conditions of 50 to 1000 mM. 15. The method of claim 10 , wherein the reaction mixture further comprises a capture DNA that is 3′ end protected, and is complementary to 8 to 20 nucleotides at the 3′ end of the product RNA. 16. The method of claim 15 , wherein the 3 ′ end of the capture DNA comprises 3′ amino, 3′-deoxy (H), 3′-phosphorylation, 3′-O-methyl, 3′-fluorophore, 3′-biotin, 3′-azide, 3′-fluoro, 3′-PEG, or a 3′-mismatched base. 17. The method of claim 10 , further comprising purifying the product RNA. 18. The method of claim 17 , further comprising removing the capture DNA after product RNA synthesis.

Assignees

Inventors

Classifications

  • Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS] · CPC title

  • Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34) · CPC title

  • C12N9/1247Primary

    DNA-directed RNA polymerase (2.7.7.6) · CPC title

  • C12P19/34Primary

    Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title

  • the label being a member of a cognate binding pair, i.e. extends to antibodies, haptens, avidin · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12325873B2 cover?
Described herein are synthetic methods for producing sequence-specific RNA oligonucleotides that eliminate impurities produced in prior art methods. In one aspect, an end-protected capture DNA complementary to a portion of the product RNA is employed. In another aspect, the template DNA is covalently or noncovalently linked to the RNA polymerase, either directly or through the use of a nontempl…
Who is the assignee on this patent?
Univ Massachusetts
What technology area does this patent fall under?
Primary CPC classification C12N9/1247. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).